Migraine trials in South Korea

2 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• No phaseTaking people
  Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic Migraine

  Where

  Ansan-si, Busan, Changwon-si, Daegu, Daejeon, Gangwon-do, Goyang, Goyang-si, Gwangju, Hwaseong, Hwaseong-si, Iksan, Incheon, Jeonju, Seongnam-si, Seoul, Suwon, Uijeongbu-si, Yongin-si

  Age

  19 years and over

  People

  3,000

  Run by

  AbbVie

  See details and how to joinNCT06603558
• Phase 3Taking people
  A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine

  Where

  Gangseo-gu, Hwaseong-si, Seoul

  Age

  18 years to 45 years

  People

  723 worldwide

  Run by

  Pfizer

  See details and how to joinNCT06641466 · EU 2024-517121-10-00